What strengths and dosage forms of Dapagliflozin + Sitagliptin Tablets are listed?

Dapagliflozin + Sitagliptin Tablets bulk supplier for pharma manufacturers

Dapagliflozin + Sitagliptin Tablets 10 mg/100 mg Suppliers & Bulk Manufacturers

Available Forms: Film-coated tablets

Available Strengths: 10 mg/100 mg

Pack Sizes: 10, 14 and 30 tablets

Reference Brands:

Category: Diabetes

Dapagliflozin + sitagliptin is a once-daily combination tablet for type 2 diabetes. PharmaTradz sources it from Indian manufacturers for export and white-label supply.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Dapagliflozin + Sitagliptin Tablets? List it or send an offer →

Product Description:

This tablet combines dapagliflozin, an SGLT2 inhibitor that removes glucose through the urine, with sitagliptin, a DPP-4 inhibitor that increases insulin release after meals. The two work in different ways, so together they lower blood sugar more than either one, with little risk of hypoglycaemia.

It is used for adults with type 2 diabetes who need more than one medicine, often alongside metformin. It is taken once a day. Dapagliflozin also has heart and kidney benefits, and sitagliptin is one of the most widely used DPP-4 inhibitors, so the pair is a common choice where both molecules are off patent.

Sourcing notes. This combination is marketed in India by several companies; it has no single innovator brand in the US or EU. Registering it in another country usually needs its own bioequivalence data and a combination rationale, so ask whether a dossier is available for your market. Room-temperature storage. Finished product, dossier and white-label enquiries are welcome.

Dapagliflozin + Sitagliptin Tablets — third party manufacturing & bulk supply

Dapagliflozin + Sitagliptin Tablets 10 mg/100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Dapagliflozin + Sitagliptin Tablets is supplied as Film-coated tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Dapagliflozin + Sitagliptin Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Dapagliflozin + Sitagliptin Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Dapagliflozin + Sitagliptin Tablets is listed as Film-coated tablets in 10 mg/100 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.